Menu
Search
|

Menu

Close
X

K2M Group Holdings Inc KTWO.OQ (NASDAQ Stock Exchange Global Select Market)

19.33 USD
+0.13 (+0.68%)
As of Feb 16
chart
Previous Close 19.20
Open 19.15
Volume 71,058
3m Avg Volume 121,834
Today’s High 19.45
Today’s Low 19.15
52 Week High 25.96
52 Week Low 16.44
Shares Outstanding (mil) 43.33
Market Capitalization (mil) 837.54
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.90 Mean rating from 10 analysts

KEY STATS

Revenue (mm, USD)
FY17
190
FY16
237
FY15
216
EPS (USD)
FY17
-0.667
FY16
-0.998
FY15
-0.979
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
3.32
8.57
Price to Book (MRQ)
vs sector
3.37
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
29.66
15.12
LT Debt to Equity (MRQ)
vs sector
29.23
11.85
Return on Investment (TTM)
vs sector
-12.08
13.54
Return on Equity (TTM)
vs sector
-15.69
14.80

EXECUTIVE LEADERSHIP

Daniel Pelak
Independent Chairman of the Board, Since 2017
Salary: --
Bonus: --
Eric Major
President, Chief Executive Officer, Director, Since 2004
Salary: $525,000.00
Bonus: $26,250.00
Gregory Cole
Chief Financial Officer, Since 2008
Salary: $339,179.00
Bonus: $8,480.00
John Kostuik
Chief Medical Officer, Director, Since 2004
Salary: $418,746.00
Bonus: $10,469.00
Paul Queally
Director, Since 2010
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

600 Hope Pkwy SE
LEESBURG   VA   20175-4428

Phone: +1703.7773155
Site: www.k2m.com

K2M Group Holdings, Inc. is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company's solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products consist of implants, disposables and instruments, which are marketed and sold primarily to hospitals for use by spine surgeons. As of December 31, 2016, its product portfolio consisted of 83 product lines that are used in complex spine, minimally invasive surgery (MIS) and degenerative surgeries. Its technologies include EVEREST, MESA, Rail 4D, Quicket Deformity, CASCADIA, CAPRI, SERENGETI, RAVINE and tifix. Its degenerative spine technologies are used to treat degenerative spine disorders and include products, such as cervical, thoracic and lumbar spinal fusion devices and interbody devices.

SPONSORED STORIES